Lippincott, Williams & Wilkins, PAIN, 3(158), p. 505-515, 2016
DOI: 10.1097/j.pain.0000000000000790
Full text: Download
KGNOP1, a mu-opioid receptor agonist/nociceptin receptor antagonist hybrid, can dually treat experimental neuropathic and nociceptive pain, more efficiently and safely than tramadol and morphine, respectively.